Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFκB/IκB system
Authors:
- David Sanz-RosaDSDavid Sanz-Rosa
- Eva CedielECEva Cediel
- Natalia de Las HerasNHNatalia de Las Heras
- Maria MianaMMMaria Miana
- Gloria BalfagónGBGloria Balfagón
- Vicente LaheraVLVicente Lahera
- Victoria CachofeiroVCVictoria Cachofeiro
- 1 June 2005
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (6) , 1167-1172
Abstract
To investigate the participation of aldosterone in the vascular inflammatory process associated with hypertension, as well as the possible involvement of the NFκB/IκB system. Male spontaneously hypertensive rats (SHR; 20–22 weeks old) untreated or treated with either the aldosterone receptor antagonist, eplerenone (100 mg/kg per day) or triple antihypertensive therapy (HHR: hydralazine + hydrochlorothiazide + reserpine; 20 + 7 + 0.15 mg/kg per day) were used in the study. Wistar–Kyoto rats (WKY) were used as a normotensive reference group. Aortic mRNA expression and plasma levels of interleukin (IL)-1β, IL-6 and tumour necrosis factor α (TNFα) were measured. Likewise, the aortic expression of the nuclear factor κB (NFκB) p50 subunit precursor, p105, and its inhibitor (IκB) were measured. SHR showed higher aortic expression of IL-1β, IL-6 and TNFα than WKY (P < 0.05) and higher plasma levels of IL-1β and IL-6 than WKY (P < 0.05). Moreover, SHR also presented increased aortic expression of nuclear transcription factor NFκB p50 subunit precursor (p105), and a reduction of its inhibitor IκB. Both eplerenone and HHR decreased blood pressure to a comparable extent (P < 0.05). This effect was accompanied by a reduction in plasma levels of IL-1β and IL-6 and aortic mRNA expression of IL-1β, IL-6 and TNFα. However, the effect of eplerenone was more marked, since eplerenone-treated rats showed significantly lower inflammatory parameters than SHR receiving HHR. In addition, both antihypertensive treatments increased IκB mRNA expression in a similar manner, but only eplerenone reduced NFκB mRNA expression. Aldosterone, as well as an increase in haemodynamic forces produced by hypertension, participate in the vascular inflammatory process associated with hypertension in SHR. This effect seems to be mediated by enhanced vascular expression of cytokines through a modification of the NFκB/IκB system.Keywords
This publication has 35 references indexed in Scilit:
- Aldosterone/salt induces renal inflammation and fibrosis in hypertensive ratsKidney International, 2003
- Aldosterone-Induced Inflammation in the Rat HeartThe American Journal of Pathology, 2002
- Spironolactone Improves Angiotensin-Induced Vascular Changes and Oxidative StressHypertension, 2002
- The Pathophysiology of Aldosterone in the Cardiovascular SystemAnnals of the New York Academy of Sciences, 2002
- Aldosterone as a Mediator in Cardiovascular InjuryCardiology in Review, 2002
- Impact of Aldosterone on Vascular PathophysiologyCongestive Heart Failure, 2002
- Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced HypertensionHypertension, 2001
- Induction of Cardiac Fibrosis by AldosteroneJournal of Molecular and Cellular Cardiology, 2000
- Aldosterone and vascular damageCurrent Hypertension Reports, 2000
- Aldosterone and potassium secretion by the cortical collecting ductKidney International, 2000